Anticancer Research 2013-12-01

Genetically-engineered human neural stem cells with rabbit carboxyl esterase can target CNS lymphoma.

Wonyoung Kang, Juyoun Jin, Heekyoung Yang, Ho Jun Seol, Kang Ho Kim, Jung-Ii Lee, Seung U Kim, Kyeung Min Joo, Do-Hyun Nam

Index: Anticancer Res. 33(12) , 5335-42, (2013)

Full Text: HTML

Abstract

Despite advances in its treatment, CNS lymphoma remains a devastating disease. Taking advantage of the tumour-tropic properties of neural stem cells (NSCs) is a novel therapeutic strategy. To apply this strategy to the treatment of CNS lymphoma, we investigated the role of NSCs expressing carboxyl esterase (HB1.F3.CE), which activates irinotecan.In order to find in vitro bystander effects of engineered NSCs, we performed cell viability assays. In vivo, the HB1.F3.CE cells were injected into the brain of mice with orthotopic CNS lymphoma. Mice were then treated with irinotecan by systemic administration.The HB1.F3.CE cells significantly inhibited the growth of Raji cells with irinotecan treatment. In vivo, the HB1.F3.CE cells migrated into the tumour and significantly reduced tumour volume. In addition, survival of mice was prolonged by treatment with HB1.F3.CE and irinotecan.Transplantation of human NSCs encoding CE into brain, combined with irinotecan therapy, may be an effective treatment regimen for CNS lymphoma.


Related Compounds

  • Carboxylesterase
  • 7-Ethyl-10-hydroxy...

Related Articles:

Pathway Pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula.

2013-03-01

[Mol. Biosyst. 9(3) , 375-85, (2013)]

Vascular smooth muscle cells isolated from adipose triglyceride lipase-deficient mice exhibit distinct phenotype and phenotypic plasticity.

2013-05-01

[Biochem. Biophys. Res. Commun. 434(3) , 534-40, (2013)]

Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.

2013-12-01

[Stem Cells Transl. Med. 2(12) , 983-92, (2013)]

Different hydrolases involved in bioactivation of prodrug-type angiotensin receptor blockers: carboxymethylenebutenolidase and carboxylesterase 1.

2013-11-01

[Drug Metab. Dispos. 41(11) , 1888-95, (2013)]

Alteration of the expression of pesticide-metabolizing enzymes in pregnant mice: potential role in the increased vulnerability of the developing brain.

2013-02-01

[Drug Metab. Dispos. 41(2) , 326-31, (2013)]

More Articles...